Anaphylaxis associated with general anaesthesia: Challenges and recent advances

Trends in Anaesthesia and Critical Care

Volumn 2, Issue 6, 2012, Pages 258-263

  Savic, Louise ^a   Wood, Philip M ^a   Savic, Sinisa ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Allergy; Anaesthesia; Anaphylaxis; Neuromuscular blocking agents

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; DYE; LATEX; NEUROMUSCULAR BLOCKING AGENT; TRYPTASE;

ACCURACY; ALLERGIC REACTION; ANAPHYLAXIS; DIAGNOSTIC TEST; DRUG SAFETY; GENERAL ANESTHESIA; HUMAN; PATIENT IDENTIFICATION; PRIORITY JOURNAL; REVIEW; SKIN TEST;

EID: 84869886796     PISSN: 22108440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tacc.2012.08.003     Document Type: Review

References (47)

1. Simons F.E., Ardusso L.R., Bilo M.B., El-Gamal Y.M., Ledford D.K., Ring J., et al. World Allergy Organization anaphylaxis guidelines: summary. J Allergy Clin Immunol 2011, 127(3):587-593. e1-22.
2. Lienhart A., Auroy Y., Pequignot F., Benhamou D., Warszawski J., Bovet M., et al. Survey of anesthesia-related mortality in France. Anesthesiology 2006, 105(6):1087-1097.
3. Harper N.J., Dixon T., Dugue P., Edgar D.M., Fay A., Gooi H.C., et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009, 64(2):199-211.
4. Fisher M.M., Baldo B.A. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993, 12(2):97-104.
5. Moneret-Vautrin D.A., Mertes P.M. Anaphylaxis to general anesthetics. Chem Immunol Allergy 2010, 95:180-189.
6. Gurrieri C., Weingarten T.N., Martin D.P., Babovic N., Narr B.J., Sprung J., et al. Allergic reactions during anesthesia at a large United States referral center. Anesth Analg 2011, 113(5):1202-1212.
7. Mertes P.M., Alla F., Trechot P., Auroy Y., Jougla E. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011, 128(2):366-373.
8. Dewachter P., Mouton-Faivre C., Emala C.W. Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology 2009, 111(5):1141-1150.
9. Payne V., Kam P.C. Mast cell tryptase: a review of its physiology and clinical significance. Anaesthesia 2004, 59(7):695-703.
10. Fisher M.M., Baldo B.A. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998, 80(1):26-29.
11. Mertes P.M., Laxenaire M.C., Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003, 99(3):536-545.
12. Dybendal T., Guttormsen A.B., Elsayed S., Askeland B., Harboe T., Florvaag E. Screening for mast cell tryptase and serum IgE antibodies in 18 patients with anaphylactic shock during general anaesthesia. Acta Anaesthesiol Scand 2003, 47(10):1211-1218.
13. Mayer D.E., Krauskopf A., Hemmer W., Moritz K., Jarisch R., Reiter C. Usefulness of post mortem determination of serum tryptase, histamine and diamine oxidase in the diagnosis of fatal anaphylaxis. Forensic Science International 2011, 212(1-3):96-101.
14. Ewan P.W., Dugue P., Mirakian R., Dixon T.A., Harper J.N., Nasser S.M. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy 2010, 40(1):15-31.
15. Porri F., Lemiere C., Birnbaum J., Guilloux L., Lanteaume A., Didelot R., et al. Prevalence of muscle relaxant sensitivity in a general population: implications for a preoperative screening. Clin Exp Allergy 1999, 29(1):72-75.
16. Tamayo E., Javier Alvarez F., Rodriguez-Ceron G., Gomez-Herreras J.I., Fernandez A., Castrodeza J. Prevalence of positive prick test to neuromuscular blocking drugs in the surgical population. Br J Clin Pharmacol 2006, 62(4):506-507.
17. Hagau N., Gherman-Ionica N., Hagau D., Tranca S., Sfichi M., Longrois D. Is a positive history of non-anaesthetic drug allergy a predictive factor for positive allergy tests to anaesthetics?. Br J Clin Pharmacol 2012, 73(3):460-466.
18. Baldo B.A., Fisher M.M. Substituted ammonium ions as allergenic determinants in drug allergy. Nature 1983, 306(5940):262-264.
19. Baldo B.A., Fisher M.M., Pham N.H. On the origin and specificity of antibodies to neuromuscular blocking (muscle relaxant) drugs: an immunochemical perspective. Clin Exp Allergy 2009, 39(3):325-344.
20. Laroche D., Chollet-Martin S., Leturgie P., Malzac L., Vergnaud M.C., Neukirch C., et al. Evaluation of a new routine diagnostic test for immunoglobulin e sensitization to neuromuscular blocking agents. Anesthesiology 2011, 114(1):91-97.
21. Fisher M., Rose M.A. Follow-up of patients after testing for anaesthetic allergy. Anaesth Intensive Care 2011, 39(6):1160.
22. Fisher M.M., Doig G.S. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf 2004, 27(6):393-410.
23. Florvaag E., Johansson S.G., Oman H., Venemalm L., Degerbeck F., Dybendal T., et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol Scand 2005, 49(4):437-444.
24. Johansson S.G., Florvaag E., Oman H., Poulsen L.K., Mertes P.M., Harper N.J., et al. National pholcodine consumption and prevalence of IgE-sensitization: a multicentre study. Allergy 2010, 65(4):498-502.
25. Florvaag E., Johansson S.G., Irgens A., de Pater G.H. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market. Allergy 2011, 66(7):955-960.
26. Naguib M. Sugammadex: another milestone in clinical neuromuscular pharmacology. Anesth Analg 2007, 104(3):575-581.
27. Funnell A.E., Griffiths J., Hodzovic I. A further case of rocuronium-induced anaphylaxis treated with sugammadex. Br J Anaesth 2011, 107(2):275-276.
28. Kawano T., Tamura T., Hamaguchi M., Yatabe T., Yamashita K., Yokoyama M. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. J Clin Anesth 2012, 24(1):62-64.
29. Clarke R.C., Sadleir P.H., Platt P.R. The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 2012, 67(3):266-273.
30. Godai K., Hasegawa-Moriyama M., Kuniyoshi T., Kakoi T., Ikoma K., Isowaki S., et al. Three cases of suspected sugammadex-induced hypersensitivity reactions. Br J Anaesth 2012, 109(2):216-218.
31. Bezu C., Coutant C., Salengro A., Darai E., Rouzier R., Uzan S. Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol 2011, 20(1):e55-e59.
32. Mertes P.M., Malinovsky J.M., Mouton-Faivre C., Bonnet-Boyer M.C., Benhaijoub A., Lavaud F., et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 2008, 122(2):348-352.
33. Raut C.P., Hunt K.K., Akins J.S., Daley M.D., Ross M.I., Singletary S.E., et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 2005, 104(4):692-699.
34. Scherer K., Studer W., Figueiredo V., Bircher A.J. Anaphylaxis to isosulfan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006, 96(3):497-500.
35. Haque R.A., Wagner A., Whisken J.A., Nasser S.M., Ewan P.W. Anaphylaxis to patent blue V: a case series and proposed diagnostic protocol. Allergy 2010, 65(3):396-400.
36. Johansson S.G., Nopp A., Oman H., Stahl-Skov P., Hunting A.S., Guttormsen A.B. Anaphylaxis to patent blue V. II. A unique IgE-mediated reaction. Allergy 2010, 65(1):124-129.
37. Manson A.L., Juneja R., Self R., Farquhar-Smith P., Macneill F., Seneviratne S.L. Anaphylaxis to patent blue V: a case series. Asia Pac Allergy 2012, 2(1):86-89.
38. Garvey L.H., Kroigaard M., Poulsen L.K., Skov P.S., Mosbech H., Venemalm L., et al. IgE-mediated allergy to chlorhexidine. J Allergy Clin Immunol 2007, 120(2):409-415.
39. Jee R., Nel L., Gnanakumaran G., Williams A., Eren E. Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg?. Br J Anaesth 2009, 103(4):614-615.
40. Beatty P., Kumar N., Ronald A. A complicated case of chlorhexidine-associated anaphylaxis. Anaesthesia 2011, 66(1):60-61.
41. Parkes A.W., Harper N., Herwadkar A., Pumphrey R. Anaphylaxis to the chlorhexidine component of Instillagel: a case series. Br J Anaesth 2009, 102(1):65-68.
42. Nagendran V., Wicking J., Ekbote A., Onyekwe T., Garvey L.H. IgE-mediated chlorhexidine allergy: a new occupational hazard?. Occup Med 2009, 59(4):270-272.
43. Murphy A., Campbell D.E., Baines D., Mehr S. Allergic reactions to propofol in egg-allergic children. Anesth Analg 2011, 113(1):140-144.
44. Bhole M.V., Manson A.L., Seneviratne S.L., Misbah S.A. IgE-mediated allergy to local anaesthetics: separating fact from perception: a UK perspective. Br J Anaesth 2012, 108(6):903-911.
45. Mallal S., Nolan D., Witt C., Masel G., Martin A.M., Moore C., et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 2002, 359(9308):727-732.
46. Ko T.M., Chung W.H., Wei C.Y., Shih H.Y., Chen J.K., Lin C.H., et al. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. J Allergy Clin Immunol 2011, 128(6):1266-1276. e11.
47. Hung S.I., Chung W.H., Liou L.B., Chu C.C., Lin M., Huang H.P., et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 2005, 102(11):4134-4139.